Praxis Precision Medicines, Inc. (PRAX) vs Spyre Therapeutics, Inc. (SYRE)
Praxis Precision Medicines, Inc. and Spyre Therapeutics, Inc. are both Biotechnology companies. Praxis Precision Medicines, Inc. and Spyre Therapeutics, Inc. are of similar size ($7.9B and $7.7B). Praxis Precision Medicines, Inc. grew revenue faster over the last twelve months: 249.5% against −81.8%. Across the 12 metrics below, Spyre Therapeutics, Inc. leads on 7 and Praxis Precision Medicines, Inc. on 5.
Valuation
Profitability
| Metric | PRAX | SYRE | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (38.86%) | (28.52%) | (57.72%) |
| Return on assets | (36.80%) | (20.90%) | (49.22%) |
| Return on invested capital | (40.58%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack